February 2011
DePuy Hip Implant Recall Compensation Plan May Not Be Enough
Posted Thu, 02/24/2011 - 14:40
In the Summer of 2010 DePuy Orthopaedics, a subsidiary of Johnson & Johnson, issued a recall of it’s ASR XL Acetabular System and DePuy ASR Hip Resurfacing System. As part of the recall, DePuy put together guidelines for patients on what to do and how to get compensated. DePuy has stated that they intend to cover reasonable and customary costs of testing and treatment, including revision surgery, if needed. They also intend to reimburse patients for reasonable out of pocket expenses. However, before anyone commits to the program, they should figure out if the compensation is enough for them.
Filed under:
by admin
Too Little Too Late: DePuy’s Withdrawal and Recall of its ASR Hip Replacement
Posted Wed, 02/23/2011 - 15:02
DePuy’s withdrawal from the market and subsequent recall of the defective DePuy ASR hip implant system has since been met with accusations of “too little too late” from the medical community. Evidence has surfaced that DePuy Orthopaedics was well aware of problems with its implant and failed to take appropriate precautions to safeguard its consumers when these problems came to light.
Filed under:
by admin
FDA Website Now Includes Metal-on-Metal Hip Implant Information
Posted Wed, 02/16/2011 - 14:47
In response to the general confusion about problems caused by the DePuy ASR hip implant system, the FDA has created a website providing useful information for those seeking answers to their questions about metal-on-metal hip implant systems.
Filed under:
by admin
DePuy ASR Hip Implant Is One Of Many Recalled Untested Devices That Were FDA Approved
Posted Tue, 02/15/2011 - 14:58
A new study released on Monday, February 14, states that most medical devices recalled in the recent years by the Food and Drug Administration (FDA) were not rigorously studied or tested prior to getting FDA approval for sale. It reported that out of 113 high-priority recalls initiated by the FDA between 2005 and 2009 80 of the recalls, or 71%, involved devices that received FDA approval through a regulatory process that requires little or no testing.
by admin
Johnson & Johnson Reserves an Inadequate Amount to Settle DePuy ASR Recall Cases
Posted Fri, 02/11/2011 - 14:02
Johnson & Johnson recently announced it has set aside $922 million to cover legal fees and settlement costs due to the recall of defective hip implants produced by DePuy Orthopaedics, one of its subsidiary companies. Last August, DePuy issued a recall of the DePuy ASR XL Acetabular System and DePuy ASR Hip Resurfacing System because of high failure rates of the devices.
Filed under:
by admin
Metallosis, A Dangerous Condition Caused by the Defective DePuy ASR Hip Implant System, Makes Its Primetime Television Debut
Posted Wed, 02/09/2011 - 14:20
FOX’s hit show “House, M.D.” follows Dr. House and his team of doctors who work in the elite Diagnostics department. Every episode focuses on one patient who is very ill and the team tries to pinpoint the ailment, which is usually rare and obscure. On the last episode, which aired on Monday, February 7, 2011, the patient was an older woman on the brink of death. After a series of unethical treatments interposed with personal storyline drama, House figures out that the woman is suffering from metallosis due to high levels of cobalt in her blood which was caused by her hip implant.
Filed under:
by admin
DEPUY ASR HIP IMPLANT LITIGATION HEARING HELD IN FLORIDA - FEDERAL CASES MOVING FORWARD
Posted Tue, 02/08/2011 - 15:05
February 8, 2011 -- West Palm Beach, Florida -- Federal Judge David Katz held his second hearing on the ongoing DePuy Orthopaedics ASR Hip Implant Products Liability Litigation proceeding in the West Palm Beach federal courthouse today at 1:00 pm. Some 50 attorneys representing plaintiffs and defendants attended the hearing.
Filed under:
by admin
Defective Component of Recalled DePuy ASR Is Part of Implant System Not Approved By FDA
Posted Tue, 02/08/2011 - 14:48
The acetabular (cup) component of the recently recalled DePuy ASR hip replacement system is also found in a hip system not currently approved by the FDA. The component was only approved for marketing by the FDA when it was included with a hip system which DePuy insisted did not warrant the rigorous testing required for new devices.
Filed under:
by admin
